Acquired haemophilia in a patient with gram-negative urosepsis and bladder cancer

Haemophilia

Volumn 11, Issue 2, 2005, Pages 181-185

  Kreuter, M ^a   Retzlaff, S ^a   Enser Weis, U ^b   Berdel, W E ^a   Mesters, Rolf M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Deparment of Hematology/Oncology   (Germany)

Author keywords

Acquired haemophilia; Cancer; Sepsis

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; CILASTATIN PLUS IMIPENEM; CYCLOPHOSPHAMIDE; GENTAMICIN; IMMUNOGLOBULIN; IMMUNOSORBA; PIPERACILLIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STAPHYLOCOCCUS PROTEIN A; STEROID; THROMBOPLASTIN; VANCOMYCIN;

AGED; ANTIBODY TITER; ARTICLE; BLADDER CANCER; BLEEDING DISORDER; BLOOD CLOTTING TEST; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CHOLECYSTECTOMY; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROBACTER CLOACAE; FOLLOW UP; GRAM NEGATIVE SEPSIS; HEMATOMA; HEMATOTHORAX; HEMOPHILIA A; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; PANCREATITIS; PAPILLARY CARCINOMA; PLASMAPHERESIS; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; URINARY TRACT INFECTION;

AGED; CARCINOMA, PAPILLARY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; SEPSIS; URINARY BLADDER NEOPLASMS;

EID: 16344385620     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01066.x     Document Type: Article

References (32)

1. Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9: 331-54.
2. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
3. Kessler CM, Ludlam CA. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. Sem Hematol 1993; 30: 22-7.
4. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81: 1513-20.
5. Bossi P, Cabane J, Ninet J et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105 400-8.
6. Michiels JJ. Acquired hemophilia A in women postpartum: clinical manifestations, diagnosis and treatment. Clin Appl Thromb Hemost 2000; 6: 82-6.
7. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired hemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
8. Gill JC. The role of genetics in inhibitor formation. Thromb Haemost 1999; 82: 500-4.
9. Yamamoto K, Niiya K, Shigematu T et al. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome. Int J Hematol 2000; 72: 517-9.
10. Laporte F, Cestac P, Favre V et al. Treatment of a septic patient with acquired haemophilia. Rev Med Intern 2003; 24: 692-5.
11. Kurczynski EM, Penner JA. Activated prothrombin concentrate for patients with factor VIII inhibitors. N Engl J Med 1974; 291 164-7.
12. Söhngen D, Specker C, Bach D et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997; 74 89-93.
13. Ji L, Yang R, Yang D et al. Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients. Haemophilia 1998; 4: 721-4.
14. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
15. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004; 2 899-909.
16. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004; 10: 169-73.
17. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose IVIG. Blood 1995; 86: 797-804.
18. Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg BM, Nilsson IM. Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Haemophilia 1998; 4: 16-20.
19. Knobl P, Derfler K, Korninger Let al. Elimination of acquired factor VIII antibodies by extracorporeal antibody-based immuno-adsorption (Ig-Therasorb). Thromb Haemost 1995; 74: 1035-8.
20. Slocombe GW, Newland AC, Colvin MP, Colvin BT. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 1981; 47: 577-85.
21. Sunagawa T, Uezu Y, Kadena K, Tokuyama K, Kinjo F, Saito A. Successful treatment of a non-haemophilic patient with inhibitor to factor VIII by double-filtration plasmapheresis. Br J Haematol 1999; 104: 465-7.
22. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thrombo Haemost 1993; 70: 753-7.
23. Shaffer LG, Phillips MD. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Int Med 1997; 127: 206-9.
24. Bayer RL, Lichtma SM, Allen SL et al. Acquired factor VIII inhibitors-successful treatment with an oral outpatient regimen. Am J Hematol 1999; 60: 70-1.
25. Lian EC, Larcada AF, Chiu AY. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Int Med 1989; 110: 774-8.
26. Sallah S, Wan YW. Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia. Blood 2003; 101: 943-5.
27. Au WY, Lam CC, Kwong YL. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Haemophilia 2004; 10 98-100.
28. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with selective hemophilia. Blood 2004; 103: 4424-8.
29. Sallah S, Wan YW. Inhibitors against factor VIII in patients with cancer, analysis of 41 patients. Cancer 2001; 91: 1067-4.
30. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 342: 586-92.
31. Rosen JP. Bleeding problems in cancer patients. Hematol Oncol Clin North Am 1992; 6: 1315-8.
32. Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK haemophilia centre doctors' organization. Br J Haematol 2000; 111: 78-91.